Wordt geladen...
Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases
Background: In the last years, inflammatory bowel disease (IBD) and hepatitis C virus (HCV) infection management has completely changed. However, the role of direct-acting antivirals (DAAs) and the correct timing of antiviral drugs administration in IBD patients needing biologics has not been evalua...
Bewaard in:
| Gepubliceerd in: | Front Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5702483/ https://ncbi.nlm.nih.gov/pubmed/29209223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00867 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|